Is it legal to sell semaglutide — and what that means for you

You've seen semaglutide advertised somewhere it probably shouldn't be

Picture this: you're scrolling through social media on a Tuesday evening and an ad appears offering semaglutide pens, dispatched within 48 hours, no appointment necessary. It looks professional. The price is noticeably lower than anything you've seen from a registered clinic. The question that naturally follows is whether the seller is doing anything illegal, and if you want a detailed answer to that specific question, our page on whether it is illegal to sell semaglutide covers the law in full, but the short answer is yes, almost certainly.

Under the Human Medicines Regulations 2012, semaglutide is classified as a prescription-only medicine. That classification carries a clear legal consequence: the medicine can only be sold or supplied to a patient when two conditions are both met. First, a prescriber who is authorised under UK law must have assessed the patient and issued a prescription. Second, the medicine must be dispensed by a pharmacy registered with the GPhC. Remove either condition and the supply is unlawful, regardless of how the seller describes themselves or what assurances they give.

The MHRA has been unequivocal on this point. Its public guidance makes clear that GLP-1 medicines are not assessed or approved for quick or cosmetic weight loss, and that selling them outside the proper prescription route is a serious regulatory breach. You can read more about the specific legal question on our page covering whether semaglutide is legal and what that means for how it can be sold.

What lawful semaglutide supply actually looks like

A lawful transaction involving semaglutide follows a predictable sequence, and once you know it, the unlawful alternatives become easy to spot. It begins with a clinical consultation (a real assessment of your medical history, current medicines, BMI, and any weight-related conditions) conducted or reviewed by a prescriber who holds the appropriate authorisation under UK law. The consultation is not a formality. It exists because semaglutide is not suitable for everyone, and the prescriber carries professional and legal responsibility for each prescription they issue.

Once the prescription exists, dispensing can only happen at a GPhC-registered pharmacy. That registration is publicly verifiable: the GPhC maintains a searchable register at pharmacyregulation.org/registers, and every legitimate online pharmacy will have a registration number you can check. At nume, our GPhC premises registration number is 9012878, you can confirm it on the register right now if you want to.

The medicine itself must come from the licensed UK supply chain, authorised distributors working with manufacturers such as Novo Nordisk for Wegovy. This matters because it is the only way to be confident the product is genuine, stored correctly, and at the stated concentration. For an overview of the semaglutide products currently licensed in the UK, our semaglutide information page sets out the approved formulations clearly.

Why the MHRA's enforcement record matters when you're making a decision

The scale of the counterfeit and illicit supply problem in the UK is not theoretical. The MHRA has publicly documented the seizure of approximately 20 million doses of illegally traded weight-loss medicines, worth around £45 million, and in October 2025 officers raided the first known UK site manufacturing counterfeit tirzepatide pens, in Northampton. Earlier enforcement actions recovered fake pens that contained insulin rather than the labelled medicine. People were hospitalised.

The pattern with unlawful sellers follows a recognisable shape: prices sit noticeably below the market range, a prescription is offered as a tick-box exercise or not mentioned at all, and the product sometimes arrives from outside the UK or in unfamiliar packaging. If you want to see what this looks like in practice, our page on semaglutide examples walks through real-world cases that illustrate the difference between lawful and unlawful supply. The MHRA asks anyone who encounters a suspected unlicensed seller to report it through the Yellow Card scheme, which handles both adverse event reports and reports of suspect medicines and sellers.

For those researching this topic because they want to understand whether a specific seller they've found is operating lawfully, our page on who can legally sell semaglutide works through the specific criteria in detail. The short version: if there is no GPhC registration you can verify, walk away.

How to access semaglutide through the right route

Wegovy (the brand name for semaglutide licensed for weight management in the UK) is available on the NHS through specialist weight management services, though waiting lists are often long. It is also available privately through regulated online pharmacies, which is the route most people using a service like ours take. Since June 2026, the MHRA has also approved Wegovy tablets, making it the first oral GLP-1 medicine licensed for weight management in the UK, a development worth knowing about if injections have put you off exploring the option.

The private route involves paying for the consultation, prescription and medicine directly, but it means no waiting list and no referral needed. The clinical assessment is still real, a prescriber reviews your health information and decides whether treatment is appropriate. At nume, that review is carried out the same day by a GPhC-registered Independent Prescriber, a real clinician rather than an automated system, and the medicine is dispatched once approved, arriving free via tracked next-working-day delivery in plain packaging. You can read about what the process involves on our Wegovy where to buy page, or explore the full range of weight-loss treatment options we offer.

If you'd like to find out whether you meet the clinical criteria, check your eligibility with a free consultation and our prescribers will review your details the same day.